Recombinant KRT20 anticorps (AA 196-323)
Aperçu rapide pour Recombinant KRT20 anticorps (AA 196-323) (ABIN7477451)
Antigène
Voir toutes KRT20 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 196-323
-
Immunogène
- Recombinant fragment of human KRT20 protein (around aa 196-323) (exact sequence is proprietary)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC 1:100-1:200
-
Commentaires
-
Positive Control: Colon mucosa: Staining should be strong at the surface and at least moderate at the basis of krypts.
Negative Control: Tonsil: All cells must stain negative.
-
Protocole
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- KRT20 (Keratin 20 (KRT20))
-
Autre désignation
- Cytokeratin 20
-
Sujet
- CK20, Cytokeratin-20, K20, KA20, Keratin 20, keratin 20, type I, Keratin type I cytoskeletal 20, Keratin-20, KRT20,Cytokeratin 20 antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- P35900
Antigène
-